Loading
Latest filing published 21 Nov 2008 for RxElite, Inc., €47k.
No signal scores available.
Shannon Marie Stith discloses dealings in RxElite, Inc. to SEC (Form 4). Between 8 August 2008 and 24 September 2008, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 21 November 2008 came the latest disclosure, a share grant for €47k in RxElite, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations